Jincai Wu

802 total citations
29 papers, 566 citations indexed

About

Jincai Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jincai Wu has authored 29 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Jincai Wu's work include Ferroptosis and cancer prognosis (11 papers), RNA modifications and cancer (8 papers) and Cancer, Lipids, and Metabolism (5 papers). Jincai Wu is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), RNA modifications and cancer (8 papers) and Cancer, Lipids, and Metabolism (5 papers). Jincai Wu collaborates with scholars based in China. Jincai Wu's co-authors include Jinfang Zheng, Dafeng Xu, Guo‐Ming Shi, Meiyu Hu, Zhijun Wang, Feizhen Wu, Jiachu Li, Kang–Da Liu, Yang Xu and Jia Fan and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

Jincai Wu

27 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jincai Wu China 12 309 185 138 126 106 29 566
Jiachu Li China 9 345 1.1× 123 0.7× 120 0.9× 35 0.3× 123 1.2× 12 546
Di‐Peng Ou China 11 279 0.9× 182 1.0× 137 1.0× 62 0.5× 268 2.5× 14 628
Oriol Arpí Spain 15 359 1.2× 149 0.8× 376 2.7× 126 1.0× 64 0.6× 24 710
Ranjan Prasad Devbhandari China 7 231 0.7× 152 0.8× 91 0.7× 46 0.4× 47 0.4× 10 457
Emanuela Balladore Italy 8 272 0.9× 132 0.7× 405 2.9× 67 0.5× 160 1.5× 14 771
Yi‐Hung Carol Tan United States 17 344 1.1× 90 0.5× 255 1.8× 200 1.6× 54 0.5× 32 705
Nerissa Mendoza United States 8 335 1.1× 98 0.5× 229 1.7× 245 1.9× 217 2.0× 10 620
Yingfu Liu China 14 297 1.0× 131 0.7× 167 1.2× 65 0.5× 18 0.2× 19 559
Lehang Lin China 14 627 2.0× 377 2.0× 165 1.2× 128 1.0× 90 0.8× 18 855
Veerabrahma Pratap Seshachalam Singapore 9 430 1.4× 208 1.1× 100 0.7× 146 1.2× 28 0.3× 12 657

Countries citing papers authored by Jincai Wu

Since Specialization
Citations

This map shows the geographic impact of Jincai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jincai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jincai Wu more than expected).

Fields of papers citing papers by Jincai Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jincai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jincai Wu. The network helps show where Jincai Wu may publish in the future.

Co-authorship network of co-authors of Jincai Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jincai Wu. A scholar is included among the top collaborators of Jincai Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jincai Wu. Jincai Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Jing, et al.. (2025). Prognostic impact of visceral and subcutaneous fat area in stage I-III colon cancer patients with cachexia: a population-based multicenter study. Frontiers in Nutrition. 12. 1538285–1538285. 1 indexed citations
2.
Liu, Luzheng, et al.. (2024). A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 23. 2234018783–2234018783.
3.
Chen, Jiacheng, et al.. (2024). Prognostic value of oxidative phosphorylation-related genes in hepatocellular carcinoma. Discover Oncology. 15(1). 258–258. 2 indexed citations
4.
Chen, Cheng, et al.. (2023). Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma. Cancer Biomarkers. 39(4). 361–370. 6 indexed citations
5.
6.
Wu, Jincai, et al.. (2023). DERL2 (derlin 2) stabilizes BAG6 (BAG cochaperone 6) in chemotherapy resistance of cholangiocarcinoma. Journal of Physiology and Biochemistry. 80(1). 81–97. 2 indexed citations
7.
Tang, Rong, Jinfang Zheng, Jincai Wu, et al.. (2023). Secukinumab plays a synergistic role with starvation therapy in promoting autophagic cell death of hepatocellular carcinoma via inhibiting IL-17A-increased BCL2 level. In Vitro Cellular & Developmental Biology - Animal. 59(5). 381–393. 4 indexed citations
8.
Shao, Guoliang, Xu Zhu, Weijia Fang, et al.. (2022). Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma. Liver Cancer. 12(2). 116–128. 7 indexed citations
9.
10.
Xu, Dafeng, Yu Wang, Jincai Wu, et al.. (2021). ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway. Cell Death and Disease. 12(2). 162–162. 46 indexed citations
11.
Xu, Dafeng, et al.. (2021). Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma. Cancer Cell International. 21(1). 621–621. 16 indexed citations
12.
Xu, Dafeng, Xiangmei Liu, Jincai Wu, et al.. (2020). LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX. Cancer Biology & Therapy. 21(10). 927–936. 10 indexed citations
13.
Xu, Dafeng, Yu Wang, Jincai Wu, et al.. (2020). <p>Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma</p>. OncoTargets and Therapy. Volume 13. 8125–8140. 10 indexed citations
14.
Xu, Dafeng, Yu Wang, Jincai Wu, et al.. (2020). MTIF2 impairs 5 fluorouracil-mediated immunogenic cell death in hepatocellular carcinoma in vivo: Molecular mechanisms and therapeutic significance. Pharmacological Research. 163. 105265–105265. 11 indexed citations
15.
Xu, Dafeng, Yu Wang, Xiangmei Liu, et al.. (2020). Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. Pharmacological Research. 164. 105370–105370. 42 indexed citations
16.
Ren, Ning, Jincai Wu, Qiongzhu Dong, et al.. (2011). Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma. Cancer Research. 71(9). 3278–3286. 17 indexed citations
17.
Fu, Liyun, Hu‐Liang Jia, Qiongzhu Dong, et al.. (2009). Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses. BMC Cancer. 9(1). 49–49. 57 indexed citations
18.
Wu, Jincai, Bingsheng Sun, Ning Ren, Qing‐Hai Ye, & Lun–Xiu Qin. (2009). Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH. Journal of Cancer Research and Clinical Oncology. 136(4). 595–601. 19 indexed citations
19.
Ke, Ai‐Wu, Guo‐Ming Shi, Jian Zhou, et al.. (2008). Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma #. Hepatology. 49(2). 491–503. 184 indexed citations
20.
Fan, Jia, Lun–Xiu Qin, Hui‐Chuan Sun, et al.. (2008). [Primary experience of the anatomical laparoscopic left lateral hepatic lobectomy procedure for benign and malignant liver tumors].. PubMed. 46(21). 1621–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiachu Li Breakdown of academic impact, for papers by Di‐Peng Ou Breakdown of academic impact, for papers by Oriol Arpí Breakdown of academic impact, for papers by Ranjan Prasad Devbhandari Breakdown of academic impact, for papers by Emanuela Balladore Breakdown of academic impact, for papers by Yi‐Hung Carol Tan Breakdown of academic impact, for papers by Nerissa Mendoza Breakdown of academic impact, for papers by Yingfu Liu Breakdown of academic impact, for papers by Lehang Lin Breakdown of academic impact, for papers by Veerabrahma Pratap Seshachalam
Rankless by CCL
2026